AAAAAA
Results: 1-25/33
Authors:
Soriano, FG
Virag, L
Jagtap, P
Szabo, E
Mabley, JG
Liaudet, L
Marton, A
Hoyt, DG
Murthy, KGK
Salzman, AL
Southan, GJ
Szabo, C
Citation: Fg. Soriano et al., Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation, NAT MED, 7(1), 2001, pp. 108-113
Authors:
Soejima, K
Traber, LD
Schmalstieg, FC
Hawkins, H
Jodoin, JM
Szabo, C
Szabo, E
Virag, L
Salzman, A
Traber, DL
Citation: K. Soejima et al., Role of nitric oxide in vascular permeability after combined burns and smoke inhalation injury (vol 163, pg 745, 2001), AM J R CRIT, 164(5), 2001, pp. 909-909
Authors:
Mabley, JG
Jagtap, P
Perretti, M
Getting, SJ
Salzman, AL
Virag, L
Szabo, E
Soriano, FG
Liaudet, L
Abdelkarim, GE
Hasko, G
Marton, A
Southan, GJ
Szabo, C
Citation: Jg. Mabley et al., Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase, INFLAMM RES, 50(11), 2001, pp. 561-569
Authors:
Soriano, FG
Virag, L
Szabo, C
Citation: Fg. Soriano et al., Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly (ADP-ribose) polymerase activation, J MOL MED-J, 79(8), 2001, pp. 437-448
Authors:
Virag, L
Szabo, C
Citation: L. Virag et C. Szabo, Purines inhibit poly(ADP-ribose) polymerase activation and modulate oxidant-induced cell death, FASEB J, 15(1), 2001, pp. 99-107
Authors:
Scott, GS
Hake, P
Kean, RB
Virag, L
Szabo, C
Hooper, DC
Citation: Gs. Scott et al., Role of poly(ADP-ribose) synthetase activation in the development of experimental allergic encephalomyelitis, J NEUROIMM, 117(1-2), 2001, pp. 78-86
Authors:
Szabo, E
Virag, L
Bakondi, E
Gyure, L
Hasko, G
Bai, P
Hunyadi, J
Gergely, P
Szabo, C
Citation: E. Szabo et al., Peroxynitrite production, DNA breakage, and poly(ADP-ribose) polymerase activation in a mouse model of oxazolone-induced contact hypersensitivity, J INVES DER, 117(1), 2001, pp. 74-80
Authors:
Eaves-Pyles, T
Murthy, K
Liaudet, L
Virag, L
Ross, G
Soriano, FG
Szabo, C
Salzman, AL
Citation: T. Eaves-pyles et al., Flagellin, a novel mediator of Salmonella-induced epithelial activation and systemic inflammation: I kappa B alpha degradation, induction of nitric oxide synthase, induction of proinflammatory mediators, and cardiovascular dysfunction, J IMMUNOL, 166(2), 2001, pp. 1248-1260
Authors:
Lohinai, Z
Stachlewitz, R
Virag, L
Szekely, AD
Hasko, G
Szabo, C
Citation: Z. Lohinai et al., Evidence for reactive nitrogen species formation in the gingivomucosal tissue, J DENT RES, 80(2), 2001, pp. 470-475
Authors:
Virag, L
Iost, N
Opincariu, M
Szolnoky, J
Szecsi, J
Bogats, G
Szenohradszky, P
Varro, A
Papp, JG
Citation: L. Virag et al., The slow component of the delayed rectifier potassium current in undiseased human ventricular myocytes, CARDIO RES, 49(4), 2001, pp. 790-797
Authors:
Liaudet, L
Szabo, E
Timashpolsky, L
Virag, L
Cziraki, A
Szabo, C
Citation: L. Liaudet et al., Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamidein a rat model of myocardial infarction: long-term morphological and functional consequences, BR J PHARM, 133(8), 2001, pp. 1424-1430
Authors:
Varro, A
Takacs, J
Nemeth, M
Hala, O
Virag, L
Iost, N
Balati, B
Agoston, M
Vereckei, A
Pastor, G
Delbruyere, M
Gautier, P
Nisato, D
Papp, JG
Citation: A. Varro et al., Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone, BR J PHARM, 133(5), 2001, pp. 625-634
Authors:
Lengyel, C
Iost, N
Virag, L
Varro, A
Lathrop, DA
Papp, JG
Citation: C. Lengyel et al., Pharmacological block of the slow component of the outward delayed rectifier current (I-Ks) fails to lengthen rabbit ventricular muscle QT(c) and action potential duration, BR J PHARM, 132(1), 2001, pp. 101-110
Authors:
Whittington, RA
Virag, L
Morishima, HO
Vulliemoz, Y
Citation: Ra. Whittington et al., Dexmedetomidine decreases extracellular dopamine concentrations in the ratnucleus accumbens, BRAIN RES, 919(1), 2001, pp. 132-138
Authors:
Mabley, J
Liaudet, L
Soriano, FG
Virag, L
Jagtap, P
Marton, A
Lorigados, CB
Gallyas, F
Szabo, E
Abdelkarim, GE
Hasko, G
Southan, GJ
Salzman, AL
Szabo, C
Citation: J. Mabley et al., Local and systemic inflammation: role of poly (ADP-ribose) synthetase activation by reactive nitrogen species, PROG INFLAM, 2001, pp. 77-98
Authors:
Virag, L
Szabo, C
Citation: L. Virag et C. Szabo, Bcl-2 protects peroxynitrite-treated thymocytes from poly(ADP-ribose) synthase (PARS)-independent apoptotic but not from PARS-mediated necrotic cell death, FREE RAD B, 29(8), 2000, pp. 704-713
Authors:
Magyar, J
Iost, N
Kortvely, A
Banyasz, T
Virag, L
Szigligeti, P
Varro, A
Opincariu, M
Szecsi, J
Papp, JG
Nanasi, PP
Citation: J. Magyar et al., Effects of endothelin-1 on calcium and potassium currents in undiseased human ventricular myocytes, PFLUG ARCH, 441(1), 2000, pp. 144-149
Authors:
Liaudet, L
Soriano, FG
Szabo, E
Virag, L
Mabley, JG
Salzman, AL
Szabo, C
Citation: L. Liaudet et al., Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase, P NAS US, 97(18), 2000, pp. 10203-10208
Authors:
Virag, L
Fazekas, T
Iost, N
Varro, A
Berlin, KD
Scherlag, BJ
Lazzara, R
Papp, JG
Citation: L. Virag et al., Effect of GLG-V-13, a Class III antiarrhythmic agent, on potassium currents in rabbit ventricular myocytes, LIFE SCI, 66(17), 2000, pp. PL253-PL258
Authors:
Varro, A
Balati, B
Iost, N
Takacs, J
Virag, L
Lathrop, DA
Csaba, L
Talosi, L
Papp, JG
Citation: A. Varro et al., The role of the delayed rectifier component I-Ks in dog ventricular muscleand Purkinje fibre repolarization, J PHYSL LON, 523(1), 2000, pp. 67-81
Authors:
Hasko, G
Kuhel, DG
Nemeth, ZH
Mabley, JG
Stachlewitz, RF
Virag, L
Lohinai, Z
Southan, GJ
Salzman, AL
Szabo, C
Citation: G. Hasko et al., Inosine inhibits inflammatory cytokine production by a posttranscriptionalmechanism and protects against endotoxin-induced shock, J IMMUNOL, 164(2), 2000, pp. 1013-1019
Authors:
Baczko, I
El-Reyani, NE
Farkas, A
Virag, L
Iost, N
Lepran, I
Matyus, P
Varro, A
Papp, JG
Citation: I. Baczko et al., Antiarrhythmic and electrophysiological effects of GYKI-16638, a novel N-(phenoxyalkyl)-N-phenylalkylamine, in rabbits, EUR J PHARM, 404(1-2), 2000, pp. 181-190
Authors:
Virag, L
Citation: L. Virag, Poly(ADP-ribose) polymerase in the immune system: Focus on reactive nitrogen intermediates and cell death, PHARM TOXIC, 2000, pp. 131-166
Authors:
Whalen, MJ
Clark, RSB
Dixon, CE
Robichaud, P
Marion, DW
Vagni, V
Graham, SH
Virag, L
Hasko, G
Stachlewitz, R
Szabo, C
Kochanek, PM
Citation: Mj. Whalen et al., Reduction of cognitive and motor deficits after traumatic brain injury in mice deficient in poly(ADP-ribose) polymerase, J CEREBR B, 19(8), 1999, pp. 835-842
Authors:
Virag, L
Scott, GS
Antal-Szalmas, P
O'Connor, M
Ohshima, H
Szabo, C
Citation: L. Virag et al., Requirement of intracellular calcium mobilization for peroxynitrite-induced poly(ADP-ribose) synthetase activation and cytotoxicity, MOLEC PHARM, 56(4), 1999, pp. 824-833